What does CUSIP M47238106 represent in this 13F holders report?

CUSIP M47238106 is the security identifier for GLMD - GALMED PHARMACEUTICALS LTD - SHS used to aggregate holder disclosures.

How many institutions held GLMD - GALMED PHARMACEUTICALS LTD - SHS in Q1 2019?

34 institutional investors reported GLMD - GALMED PHARMACEUTICALS LTD - SHS for Q1 2019. Use the holders table for investor-level position and value details.

GALMED PHARMACEUTICALS LTD - SHS (GLMD)

CUSIP: M47238106

Q1 2019 13F Holders as of 31 Mar 2019

Security type / class: Equity / SHS
Total 13F shares: 7,416,360
Total 13F value: $60,589,170
Share change: -226,787
SEC-reported price per share: $8.17
Number of holders: 34
Value change: -$1,338,068
Number of buys: 13
Number of sells: 22

Security key

M47238106

Report period

Q1 2019

Institutions

Top holders

GLMD full security history Ownership snapshot Full 13F holder table Galmed Pharmaceuticals Ltd. SEC filings Galmed Pharmaceuticals Ltd. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of GLMD - GALMED PHARMACEUTICALS LTD - SHS (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

BVF INC/IL

Disclosed value leader

BVF INC/IL

Comparable rows

0/15

Latest evidence

31 Dec 2018

13F Highest disclosed value: $12,830,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BVF INC/IL has the largest disclosed position value at $12.83M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BVF INC/IL's linked filing trail.

Disclosed position value Top 5

BVF INC/IL $12.83M

683 Capital Management, LLC $9.22M

Vivo Capital, LLC $6.63M

Nantahala Capital Management, LLC $5.7M

MEITAV INVESTMENT HOUSE LTD $4.46M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BVF INC/IL	13F Company 13F	— denominator unverified	$12,830,000 1,878,508 shares	—	31 Dec 2018
683 Capital Management, LLC	13F Company 13F	— denominator unverified	$9,221,000 1,350,000 shares	—	31 Dec 2018
Vivo Capital, LLC	13F Company 13F	— denominator unverified	$6,634,000 971,337 shares	—	31 Dec 2018
Nantahala Capital Management, LLC	13F Company 13F	— denominator unverified	$5,699,000 834,401 shares	—	31 Dec 2018
MEITAV INVESTMENT HOUSE LTD	13F Company 13F	— denominator unverified	$4,465,000 653,667 shares	—	31 Dec 2018
IBEX INVESTORS LLC	13F Company 13F	— denominator unverified	$3,415,000 500,000 shares	—	31 Dec 2018

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

7,416,360

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2019 vs Q1 2019 Across Filers

Q1 2019 holders

Holder diff

Investor	Q1 2019 Shares	Q1 2019 Shares	Share Diff	Share Chg %	Q1 2019 value	Q1 2019 value	Value change	Value Chg %